Prolacta Bioscience Provides Update on Latest SARS-CoV-2 Data and Continued Safety of Its Human Milk-Based Nutritional Products
Type: Press Releases
Topic(s): Quality & Safety
Synova Webinar: Human Donor Milk Safety, A Nurse Leadership Call to Action
Type: Events
Topic(s): Feeding Protocols Healthcare Professionals Pasteurization Quality & Safety
CE Webinar: Human Milk: A Source of Life More Than We Imagined
Type: Events
Topic(s): Conferences and Events Healthcare Professionals
Late-Onset Sepsis Reduced in Premature Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers as Part of an Exclusive Human Milk Diet
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Late-Onset Sepsis
Prolacta Bioscience Fortifiers Reduce Risk of Serious Lung Disease and Hospital Costs Among Premature Infants, Compared to Cow Milk-Based Fortifiers
Type: Press Releases
Topic(s): Bronchopulmonary Dysplasia (BPD)
Dr. Melinda Elliott Discusses the Nutritional Needs of Premature Infants in the NICU
Type: Prolacta in the News
Topic(s): Parents
CE Webinar: The Clinical Story of the Exclusive Human Milk Diet
Type: Events
Topic(s): Feeding Protocols
CE Webinar: Golden Hour (and Beyond)
Type: Events
Topic(s):
CE Webinar: Clinical Benefits and Science Behind the Exclusive Human Milk Diet
Type: Events
Topic(s):
Not finding the reference you’re looking for?
Email us at info@prolacta.com
